Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of ME-609 vs Acyclovir in Recurrent Herpes Labialis
NCT00361881Phase 3Completed
- Sponsor
- Medivir
- Start
- Jul 2006
- Primary completion
- Aug 2007
- Modality
- Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acyclovir + hydrocortisone in herpes labialis (3 arms), sponsored by Medivir. Primary endpoint: Proportion of subjects with non-ulcerative recurrences at 5 days. Started Jul 2006; status: completed.
02
Drugs
acyclovir + hydrocortisone
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT00361881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361881.